Faced with this apoptotic activity of CytC and the limitations of using this protein, [31] intended to deliver this molecule with the prohibitin-targeted nanoparticle system (PTNP) to develop an effective and safe anti-obesity therapy. This evidence concerns the gene PHB1 and obesity due to melanocortin 4 receptor deficiency.